Comment
doi: 10.1136/annrheumdis-2017-212838.
Epub 2017 Dec 29.
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis
Affiliations
- PMID: 29288209
- DOI: 10.1136/annrheumdis-2017-212838
Item in Clipboard
Comment
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis
Ann Rheum Dis.
2019 Jan.
No abstract available
Keywords: disease activity; giant cell arteritis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song.Ann Rheum Dis. 2019 Jan;78(1):e10. doi: 10.1136/annrheumdis-2017-212871. Epub 2018 Feb 10. Ann Rheum Dis. 2019. PMID: 29440039 No abstract available.
Comment on
-
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
